Kangstem Biotech Co. Ltd (217730) — Capital Reinvestment Ratio

Latest as of June 2019: 1.05x

Kangstem Biotech Co. Ltd (217730) has a Capital Reinvestment Ratio of 1.05x as of June 2019, meaning it reinvests 1% of its operating cash flow (₩1.12 Billion) in capital expenditures (₩1.18 Billion). See Kangstem Biotech Co. Ltd balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.05x

Capex / Operating Cash Flow

Operating Cash Flow

₩1.12 Billion

KRW

Capital Expenditures

₩1.18 Billion

KRW

Data as of

Jun 2019

Most recent filing

Annual Capital Reinvestment Ratio for Kangstem Biotech Co. Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Kangstem Biotech Co. Ltd from None to None. For live market cap and broader valuation context, see how much is Kangstem Biotech Co. Ltd worth.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow